Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A undifferentiated carcinoma that involves the nasopharynx.
Biomarker and diagnostic research for undifferentiated carcinoma of nasopharynx has been reported in the published literature.
2 clinical trials registered. Interventions under study include drug therapy, other interventions, procedural interventions, and biologic therapy. Pipeline includes 1 PHASE2, 1 PHASE1. Research is primarily sponsored by academic and government institutions.
203 publications have been identified in PubMed for undifferentiated carcinoma of nasopharynx. Kisho has analyzed 118 by research type. Research spans Review / Meta-Analysis (25%), Case Report / Case Series (19%), and Diagnostic / Biomarker (18%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 9:33 PM UTC
Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
25% |
Patient case studies | 23 | 19% |
Testing and diagnosis research | 21 | 18% |
Laboratory research | 21 | 18% |
Disease patterns and progression | 13 | 11% |
Clinical study results | 9 | 8% |
New treatment approaches | 2 | 2% |
Chen XC (2026). [PMID: 41579269](https://pubmed.ncbi.nlm.nih.gov/41579269/). *Endocr Pathol*. [Basic Science / Preclinical]
Lee C (2026). [PMID: 41928838](https://pubmed.ncbi.nlm.nih.gov/41928838/). *Imaging Sci Dent*. [Epidemiology / Natural History]
Wang P (2026). [PMID: 41593888](https://pubmed.ncbi.nlm.nih.gov/41593888/). *Ann Med*. [Review / Meta-Analysis]
Fischbein NJ (2026). [PMID: 41233053](https://pubmed.ncbi.nlm.nih.gov/41233053/). *Radiol Clin North Am*. [Review / Meta-Analysis]
Wang Y (2026). [PMID: 41642350](https://pubmed.ncbi.nlm.nih.gov/41642350/). *Support Care Cancer*. [Gene Therapy / Novel Therapeutics]
Duprez F (2026). [PMID: 42038372](https://pubmed.ncbi.nlm.nih.gov/42038372/). *Front Oncol*. [Review / Meta-Analysis]
Mankowski NL (2026). [PMID: 32491567](https://pubmed.ncbi.nlm.nih.gov/32491567/). *Unknown Journal*. [Basic Science / Preclinical]
Chen X (2026). [PMID: 41016490](https://pubmed.ncbi.nlm.nih.gov/41016490/). *Int J Radiat Oncol Biol Phys*. [Clinical Trial Publication]
Jian-Ping L (2026). [PMID: 41688220](https://pubmed.ncbi.nlm.nih.gov/41688220/). *Histopathology*. [Basic Science / Preclinical]
Gupta A (2026). [PMID: 41887464](https://pubmed.ncbi.nlm.nih.gov/41887464/). *J Stomatol Oral Maxillofac Surg*. [Review / Meta-Analysis]